{
  "functional_evidence_aim": "Pathogenic",
  "variants": [
    {
      "variant": "LRRK2 R1441G",
      "assessment_steps": [
        {
          "step": "1. Define the disease mechanism",
          "result": "Yes",
          "extracted_info": "LRRK2 mutations (including R1441G) cause Parkinson's disease through impaired phosphorylation at S935 and disrupted 14-3-3 binding."
        },
        {
          "step": "2. Evaluate applicability of the assay",
          "result": "Yes",
          "extracted_info": "Affinity purification and mass spectrometry methods are used to assess phosphorylation and protein interactions, directly relevant to the mechanism."
        },
        {
          "step": "3a. Evaluate validity of specific assays (basic controls)",
          "result": "No",
          "extracted_info": "No explicit mention of wild-type or null controls in the abstract; findings are based on comparative analysis of mutant vs. wild-type LRRK2."
        },
        {
          "step": "3b. Accepted/validated assay",
          "result": "Yes",
          "extracted_info": "Affinity purification and mass spectrometry are standard techniques in the field for studying phosphorylation and protein interactions."
        },
        {
          "step": "4b. No OddsPath calculation",
          "result": "Max PS3_supporting",
          "extracted_info": "No statistical OddsPath values reported; the study relies on qualitative observations of impaired 14-3-3 binding and reduced phosphorylation."
        }
      ],
      "final_evidence_strength": "PS3_supporting"
    },
    {
      "variant": "LRRK2 Y1699C",
      "assessment_steps": [
        {
          "step": "1. Define the disease mechanism",
          "result": "Yes",
          "extracted_info": "LRRK2 mutations (including Y1699C) cause Parkinson's disease through impaired phosphorylation at S935 and disrupted 14-3-3 binding."
        },
        {
          "step": "2. Evaluate applicability of the assay",
          "result": "Yes",
          "extracted_info": "Affinity purification and mass spectrometry methods are used to assess phosphorylation and protein interactions, directly relevant to the mechanism."
        },
        {
          "step": "3a. Evaluate validity of specific assays (basic controls)",
          "result": "No",
          "extracted_info": "No explicit mention of wild-type or null controls in the abstract; findings are based on comparative analysis of mutant vs. wild-type LRRK2."
        },
        {
          "step": "3b. Accepted/validated assay",
          "result": "Yes",
          "extracted_info": "Affinity purification and mass spectrometry are standard techniques in the field for studying phosphorylation and protein interactions."
        },
        {
          "step": "4b. No OddsPath calculation",
          "result": "Max PS3_supporting",
          "extracted_info": "No statistical OddsPath values reported; the study relies on qualitative observations of impaired 14-3-3 binding and reduced phosphorylation."
        }
      ],
      "final_evidence_strength": "PS3_supporting"
    },
    {
      "variant": "LRRK2 G2019S",
      "assessment_steps": [
        {
          "step": "1. Define the disease mechanism",
          "result": "Yes",
          "extracted_info": "LRRK2 mutations (including G2019S) cause Parkinson's disease through impaired phosphorylation at S935 and disrupted 14-3-3 binding."
        },
        {
          "step": "2. Evaluate applicability of the assay",
          "result": "Yes",
          "extracted_info": "Affinity purification and mass spectrometry methods are used to assess phosphorylation and protein interactions, directly relevant to the mechanism."
        },
        {
          "step": "3a. Evaluate validity of specific assays (basic controls)",
          "result": "No",
          "extracted_info": "No explicit mention of wild-type or null controls in the abstract; findings are based on comparative analysis of mutant vs. wild-type LRRK2."
        },
        {
          "step": "3b. Accepted/validated assay",
          "result": "Yes",
          "extracted_info": "Affinity purification and mass spectrometry are standard techniques in the field for studying phosphorylation and protein interactions."
        },
        {
          "step": "4b. No OddsPath calculation",
          "result": "Max PS3_supporting",
          "extracted_info": "No statistical OddsPath values reported; the study relies on qualitative observations of impaired 14-3-3 binding and reduced phosphorylation."
        }
      ],
      "final_evidence_strength": "PS3_supporting"
    }
  ],
  "overall_conclusion": "The three LRRK2 mutations (R1441G, Y1699C, G2019S) are associated with impaired 14-3-3 binding and reduced phosphorylation at S935, consistent with a pathogenic mechanism. However, the evidence strength is 'PS3_supporting' due to the absence of explicit controls, statistical OddsPath calculations, and limited variant control data in the abstract."
}